CXRs offer 'Limited Value' for Melanoma

Chicago - A recent review of routine chest X-rays for pulmonary metastasis adds weight to a growing body of evidence that CXRs have limited value in the follow-up of melanoma patients and their prolonged survival.

Related Videos
Related Content

The Connection Between COVID Lung Lesions and Skin Lesions

April 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Panel Questions Isotretinoin iPLEDGE REMS

March 31st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Photoprotection Can Improve Acne Outcomes

March 31st 2023

What's Trending in Skin Care: March 2023

March 31st 2023

The Connection Between COVID Lung Lesions and Skin Lesions

April 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Panel Questions Isotretinoin iPLEDGE REMS

March 31st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Photoprotection Can Improve Acne Outcomes

March 31st 2023

What's Trending in Skin Care: March 2023

March 31st 2023

The Connection Between COVID Lung Lesions and Skin Lesions

April 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Panel Questions Isotretinoin iPLEDGE REMS

March 31st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Photoprotection Can Improve Acne Outcomes

March 31st 2023

What's Trending in Skin Care: March 2023

March 31st 2023
© 2023 MJH Life Sciences

All rights reserved.